Delivery Order SPE2DB24D1007-SPE2DB24FBZYA

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 2.5 mg tablet in 60-count packages. The contract has a ceiling value of $7,608.78 and an ultimate completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is for the delivery of 4,567,038,422 units of the pharmaceutical product Eliquis 5 mg tablet. The firm-fixed-price delivery order, valued at $5,578.81, has a completion date of January 27, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Eliquis 2.5 mg tablets. The contract has a ceiling value of $2,375.10 and an ultimate completion date of November 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is a delivery order (SPE2DB24D2205|SPE2DB24FEAPV) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,565,971,132 units of the medication Eliquis 2.5 mg tablets. The $4,750.20 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on September 28, 2024, with a completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 2.5 mg tablets. The fixed-price delivery order, valued at $1,900.08, has a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 2.5 mg tablets. The $7,862.40 firm-fixed-price contract has a completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,216,222 units of the medication Eliquis 5 mg tablet. The $20,974.31 fixed-price delivery order has an ultimate completion date of August 25, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Eliquis 2.5 mg tablets for a ceiling value of $2,222.82. The contract is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract, a primary vehicle valued up to $999,999,999 through 2025 for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The $5,435.76 firm fixed-price contract has an ultimate completion date of August 28, 2024. This award is a delivery order placed against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing...
The U.S. Defense Logistics Agency (DLA) awarded a $1,187.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to supply 4,564,361,392 units of the prescription medication Eliquis 2.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBZYA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,190,788 units of the medication Eliquis 2.5 mg tablet. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,662.57 and an ultimate completion date of July 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This award is not designated as a set-aside.

Generated 10/17/24, 9:04 AM